Will Society Stagnate with Longevity Drugs?
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →About this video
Creator description · original textText language: English
🚀 Detailed show notes are available in the LEVITY newsletter: https://peterottsjo.beehiiv.com/
🚀 Don't forget to SUBSCRIBE to our channel: https://www.youtube.com/channel/UCQ2g_IsL0inKrkc6omolPdA?sub_confirmation=1
Can extending human lifespan cause societal stagnation? Linus Petersson, co-founder of the Swedish Longevity Cluster and author of Läkemedel Mot Åldrande (Drugs Against Aging), tackles this question head-on in a clip from episode 3 of the LEVITY Podcast.
Is the risk of stagnation worse than 110,000 people dying every day?
Linus argues that the benefits of longevity drugs could far outweigh concerns about stagnation, proposing innovative solutions to maintain societal dynamism.
LEVITY · 9 min · Source published: 2024-08-01
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.